Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 13, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2019. Go to the latest filing (Q3 2026)

21.4B USDQ4 2019
Total value of stock positions
21.4B USD
Positions
66
Share of the ten largest
50.0%

The ten largest positions Q4 2019

  1. Amazon 7.7%▼ −1.6%
  2. Meta Platforms 6.1%▲ +2.0%
  3. Adaptive Biotechnologies Cor 5.4%unchanged
  4. Netflix 5.4%▼ −18.5%
  5. Uber 5.3%▲ +162.7%
  6. Bridgebio Pharma Inc 4.4%unchanged
  7. Elevance Health 4.4%▼ −20.3%
  8. Boston Scientific 3.9%▲ +77.5%
  9. Monster Beverage 3.9%▲ +22.9%
  10. JD.com (ADR) 3.7%▼ −17.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2019

Positions Q4 2019 per 13F filing, 50 of 66
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 7.7% 889,872 1.6B USD −1.6% reduced Q2 2015 19 quarters
NFLX Netflix 5.4% 3,532,638 1.1B USD −18.5% reduced Q3 2015 18 quarters
GOOGL Alphabet Inc. (Class A) 0.3% 55,285 74.0M USD −58.1% reduced Q4 2015 17 quarters
META Meta Platforms 6.1% 6,363,574 1.3B USD +2.0% increased Q1 2016 16 quarters
Editas Medicine Inc 0.1% 733,401 21.7M USD unchanged Q1 2016 16 quarters
MSFT Microsoft 1.0% 1,369,820 216.0M USD −76.9% reduced Q2 2016 15 quarters
V Visa Inc. 0.3% 335,547 63.0M USD +33.8% increased Q3 2016 14 quarters
Liberty Media Corp Delaware 1.9% 8,628,931 396.6M USD −13.7% reduced Q1 2017 12 quarters
ELV Elevance Health 4.4% 3,086,199 932.1M USD −20.3% reduced Q2 2017 11 quarters
Biomarin Pharmaceutical Inc 0.6% 1,621,739 137.1M USD −47.0% reduced Q1 2018 8 quarters
Catalent Inc 0.4% 1,358,923 76.5M USD −4.6% reduced Q1 2018 8 quarters
BABA Alibaba Group (ADR) 0.3% 328,938 69.8M USD −85.1% reduced Q1 2018 8 quarters
CNC Centene Corporation 3.2% 10,907,112 685.7M USD −11.7% reduced Q2 2018 7 quarters
ILMN Illumina, Inc. 0.6% 408,658 135.6M USD −78.8% reduced Q2 2018 7 quarters
BSX Boston Scientific 3.9% 18,491,662 836.2M USD +77.5% increased Q3 2018 6 quarters
Exact Sciences Corp 0.9% 2,067,247 191.2M USD −5.4% reduced Q3 2018 6 quarters
AON Aon plc 0.8% 772,027 160.8M USD −2.6% reduced Q3 2018 6 quarters
Blueprint Medicines Corp 0.5% 1,306,541 104.7M USD +63.0% increased Q3 2018 6 quarters
ALGN Align Technology 0.3% 262,214 73.2M USD −61.8% reduced Q4 2018 5 quarters
MRNA Moderna 0.3% 3,321,755 65.0M USD −29.0% reduced Q4 2018 5 quarters
JD JD.com (ADR) 3.7% 22,225,867 783.0M USD −17.4% reduced Q1 2019 4 quarters
MELI MercadoLibre 1.9% 706,781 404.2M USD −12.5% reduced Q1 2019 4 quarters
Activision Blizzard Inc 1.1% 4,023,395 239.1M USD +420.7% increased Q1 2019 4 quarters
Axa Equitable HLDGS Inc 1.1% 9,048,047 224.2M USD −15.3% reduced Q1 2019 4 quarters
Covetrus Inc 0.2% 3,381,937 44.6M USD unchanged Q1 2019 4 quarters
Adaptive Biotechnologies Cor 5.4% 38,406,607 1.1B USD unchanged Q2 2019 3 quarters
UBER Uber 5.3% 38,092,013 1.1B USD +162.7% increased Q2 2019 3 quarters
Bridgebio Pharma Inc 4.4% 26,620,991 933.1M USD unchanged Q2 2019 3 quarters
MNST Monster Beverage 3.9% 12,944,911 822.6M USD +22.9% increased Q2 2019 3 quarters
CRM Salesforce 3.3% 4,367,722 710.4M USD −11.4% reduced Q2 2019 3 quarters
XYZ Block, Inc. 2.9% 10,044,042 628.4M USD +0.1% increased Q2 2019 3 quarters
LOW Lowe's 2.5% 4,424,386 529.9M USD −9.2% reduced Q2 2019 3 quarters
AIZ Assurant 1.1% 1,861,267 244.0M USD +31.6% increased Q2 2019 3 quarters
Raytheon Co 1.1% 1,043,924 229.4M USD +226.9% increased Q2 2019 3 quarters
Coupa Software Inc 1.0% 1,413,382 206.7M USD +6.0% increased Q2 2019 3 quarters
Avantor Inc 0.7% 8,344,066 151.4M USD +6.0% increased Q2 2019 3 quarters
Gardner Denver HLDGS Inc 0.2% 1,109,851 40.7M USD −86.0% reduced Q2 2019 3 quarters
NOW ServiceNow 3.6% 2,753,568 777.4M USD +55.5% increased Q3 2019 2 quarters
FTV Fortive 2.6% 7,163,848 547.2M USD +48.0% increased Q3 2019 2 quarters
Molina Healthcare Inc 1.5% 2,311,923 313.7M USD +57.3% increased Q3 2019 2 quarters
Guardant Health Inc 1.4% 3,834,753 299.6M USD +33.4% increased Q3 2019 2 quarters
Middleby Corp 1.0% 1,856,730 203.3M USD +66.4% increased Q3 2019 2 quarters
URI United Rentals 0.3% 419,058 69.9M USD +2.5% increased Q3 2019 2 quarters
EW Edwards Lifesciences 0.2% 158,573 37.0M USD −22.3% reduced Q3 2019 2 quarters
Envista HLDGS Corp 0.2% 1,133,435 33.6M USD −1.3% reduced Q3 2019 2 quarters
DDOG Datadog 0.1% 822,696 31.1M USD −8.6% reduced Q3 2019 2 quarters
Genmab A S < 0.1% 585,309 13.1M USD −1.3% reduced Q3 2019 2 quarters
Atyr Pharma Inc < 0.1% 229,283 956.0K USD unchanged Q3 2019 2 quarters
MET MetLife 1.6% 6,723,542 342.7M USD new Q4 2019 1 quarter
UNH UnitedHealth Group 1.3% 958,037 281.6M USD new Q4 2019 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 66 positions.

Breakdown by sector

  • Health Care 15.9%
  • Communication Services 11.9%
  • Consumer Discretionary 11.5%
  • Industrials 9.8%
  • Technology 8.1%
  • Financials 7.8%
  • Consumer Staples 3.9%
  • not in our coverage 31.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close